Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maolin Jiang

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Advanced Healthcare Materials|August 28, 2021
Theranostic Heterodimeric Prodrug with Dual-Channel Fluorescence Turn-On and Dual-Prodrug Activation for Synergistic Cancer TherapyMaolin Jiang, Kewei Wang, Xuan Xiao, et al.
Frontiers in Pediatrics|June 26, 2026
Clinical and genetic characteristics of children with sodium taurocholate cotransporting poly-peptide deficiencyLina Du, Mengyao Zhou, Jing Yang, et al.
Biomaterials|July 12, 2021
Amplification of tumor oxidative stresses by Poly(disulfide acetal) for multidrug resistance reversalQingyu Zong, Kewei Wang, Xuan Xiao, et al.
Medicine|December 23, 2025
Sex-specific association of the hemoglobin, albumin, lymphocyte, and platelet score with urinary incontinence: A cross-sectional studyJiasheng Liu, Jinhao Li, Pengfei Diao, et al.
The Journal of Allergy and Clinical Immunology. Global|September 2, 2025
A novel hypomorphic mutation in <i>IL2RG</i> associated with severe interstitial lung diseaseHui Liu, Haiming Yang, Hui Xu, et al.
Frontiers in Endocrinology|March 25, 2025
Associations between cardiometabolic index with kidney stones: evidence from NHANES 2007-2018Suquan Zhong, Guoliang Li, Chao Tian, et al.
BMC Urology|January 28, 2026
ZJU index and the prevalence of kidney stones in US adults: evidence from NHANES 2007-2018Suquan Zhong, Guoliang Li, Chao Tian, et al.
Science Advances|February 27, 2026
PROTAC-based synthetic lethality strategy endogenously activates systemic STING to boost antitumor immunityYe Liu, Maolin Jiang, Mengchao Ding, et al.
Nano Letters|February 26, 2021
Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic ChemotherapyFangzhou Yu, Yalan Tu, Shiwei Luo, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 8, 2024
A Synergistic Chemoimmunotherapy System Leveraging PD-L1 Blocking and Bioorthogonal Prodrug ActivationKewei Wang, Maolin Jiang, Tao Li, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Advanced Healthcare Materials|August 28, 2021
Theranostic Heterodimeric Prodrug with Dual-Channel Fluorescence Turn-On and Dual-Prodrug Activation for Synergistic Cancer TherapyMaolin Jiang, Kewei Wang, Xuan Xiao, et al.
Frontiers in Pediatrics|June 26, 2026
Clinical and genetic characteristics of children with sodium taurocholate cotransporting poly-peptide deficiencyLina Du, Mengyao Zhou, Jing Yang, et al.
Biomaterials|July 12, 2021
Amplification of tumor oxidative stresses by Poly(disulfide acetal) for multidrug resistance reversalQingyu Zong, Kewei Wang, Xuan Xiao, et al.
Medicine|December 23, 2025
Sex-specific association of the hemoglobin, albumin, lymphocyte, and platelet score with urinary incontinence: A cross-sectional studyJiasheng Liu, Jinhao Li, Pengfei Diao, et al.
The Journal of Allergy and Clinical Immunology. Global|September 2, 2025
A novel hypomorphic mutation in <i>IL2RG</i> associated with severe interstitial lung diseaseHui Liu, Haiming Yang, Hui Xu, et al.
Frontiers in Endocrinology|March 25, 2025
Associations between cardiometabolic index with kidney stones: evidence from NHANES 2007-2018Suquan Zhong, Guoliang Li, Chao Tian, et al.
BMC Urology|January 28, 2026
ZJU index and the prevalence of kidney stones in US adults: evidence from NHANES 2007-2018Suquan Zhong, Guoliang Li, Chao Tian, et al.
Science Advances|February 27, 2026
PROTAC-based synthetic lethality strategy endogenously activates systemic STING to boost antitumor immunityYe Liu, Maolin Jiang, Mengchao Ding, et al.
Nano Letters|February 26, 2021
Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic ChemotherapyFangzhou Yu, Yalan Tu, Shiwei Luo, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 8, 2024
A Synergistic Chemoimmunotherapy System Leveraging PD-L1 Blocking and Bioorthogonal Prodrug ActivationKewei Wang, Maolin Jiang, Tao Li, et al.
Pageof 3